C-Peptide
Also known as: Connecting Peptide
What Does C-Peptide Measure?
C-peptide, or connecting peptide, is a short chain of 31 amino acids that is released into the bloodstream in equal amounts to insulin when the pancreas produces insulin. It is formed when proinsulin, the precursor molecule made in the pancreatic beta cells, is split into insulin and C-peptide. Because C-peptide is released in a 1:1 ratio with insulin and has a longer half-life in the blood (about 30–35 minutes compared to insulin's 5 minutes), it serves as a reliable indirect marker of how much insulin your body is naturally producing.
Why Does C-Peptide Matter?
Measuring C-peptide is clinically significant because it helps distinguish between type 1 and type 2 diabetes, assess residual pancreatic beta-cell function, and detect insulin overproduction (such as from an insulinoma). Unlike insulin itself, C-peptide is not affected by externally injected insulin, making it invaluable for evaluating insulin secretion in people who use insulin therapy. It also helps guide treatment decisions, monitor the progression of diabetes, and evaluate hypoglycemia (low blood sugar) by determining whether low glucose is caused by the body's own insulin or by injected or oral insulin-stimulating medications.
Normal Ranges
Males
0.8–3.1 ng/mL (fasting); 1.1–4.4 ng/mL (stimulated)
Females
0.8–3.1 ng/mL (fasting); 1.1–4.4 ng/mL (stimulated)
Children
Varies by age and puberty stage; typically 0.4–2.2 ng/mL fasting
Causes of High Levels
- Type 2 diabetes with insulin resistance, where the pancreas overproduces insulin to compensate for poor cellular response
- Insulinoma, a rare insulin-secreting tumor of the pancreatic beta cells that causes excessive insulin and C-peptide production
- Obesity and metabolic syndrome, which drive increased pancreatic insulin secretion
- Cushing's syndrome (excess cortisol), which promotes insulin resistance and compensatory hyperinsulinemia
- Kidney disease or renal failure, which reduces clearance of C-peptide from the bloodstream
- Oral hypoglycemic medications (sulfonylureas, meglitinides) that stimulate pancreatic insulin release
Causes of Low Levels
- Type 1 diabetes, an autoimmune condition where the immune system destroys pancreatic beta cells, severely reducing or eliminating insulin and C-peptide production
- Long-standing type 2 diabetes with beta-cell exhaustion, where the pancreas loses its ability to produce sufficient insulin over time
How to Improve Your C-Peptide
Diet
- Adopt a low-glycemic diet rich in non-starchy vegetables, legumes, and whole grains to reduce the burden on the pancreas and lower insulin demand
- Limit added sugars and refined carbohydrates (white bread, sugary drinks) to prevent repeated insulin spikes that contribute to beta-cell stress
- Increase dietary fiber intake (aim for 25–35g per day) from sources like oats, beans, and flaxseed to slow glucose absorption and improve insulin sensitivity
- Incorporate healthy fats from avocados, olive oil, and nuts to improve insulin signaling and reduce inflammation
- Follow a Mediterranean or DASH-style eating pattern, which has been shown to improve insulin sensitivity and preserve pancreatic function
Supplements
- Berberine (500 mg, 2–3 times daily with meals) has evidence for improving insulin sensitivity and reducing compensatory C-peptide elevation in type 2 diabetes
- Magnesium (200–400 mg daily as glycinate or citrate) supports insulin receptor function and has been linked to improved glycemic control
- Chromium picolinate (200–1000 mcg daily) may enhance insulin action and improve glucose tolerance, potentially normalizing C-peptide levels
Related Biomarkers
Frequently Asked Questions
What is the difference between a C-peptide test and an insulin test?
Both tests assess insulin production, but they measure different things. The insulin test directly measures insulin in the blood, which can be confounded by injected insulin. C-peptide measures the byproduct released when the pancreas makes its own insulin, so it only reflects natural (endogenous) insulin production. This makes C-peptide more useful in people who already use insulin therapy, as injected insulin does not contain C-peptide.
Can C-peptide levels tell me if I have type 1 or type 2 diabetes?
Yes, C-peptide is a key tool for distinguishing the two. In type 1 diabetes, C-peptide levels are very low or undetectable because the autoimmune attack has destroyed the insulin-producing beta cells. In type 2 diabetes, C-peptide levels are typically normal or elevated (especially early on) because the pancreas is overworking to compensate for insulin resistance. A stimulated C-peptide test (taken after a meal or glucose drink) provides even more diagnostic clarity.
What does it mean if my C-peptide is high but I am not diabetic?
Elevated C-peptide without a diabetes diagnosis may indicate prediabetes, insulin resistance, obesity, or metabolic syndrome — conditions where the pancreas overproduces insulin to keep blood sugar in a normal range. In rare cases, a high C-peptide alongside unexplained low blood sugar (hypoglycemia) can suggest an insulinoma, a tumor of the pancreas that secretes insulin uncontrollably. Your doctor may order additional tests such as a fasting glucose, insulin level, or imaging studies to investigate further.